| Judy Jicinsky, PT | |
|
625 32nd Ave Sw, Cedar Rapids, IA 52404-3947 | |
| (319) 363-2901 | |
| (319) 363-2903 |
| Full Name | Judy Jicinsky |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 35 Years |
| Location | 625 32nd Ave Sw, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871509224 | NPI | - | NPPES |
| 0429027 | Medicaid | IA | |
| 30406 | Other | IA | WELLMARK BCBS |
| F232553 | Other | IA | MIDLANDS CHOICE |
| P00062328 | Other | IA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 02851 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Performance Therapies, Pc | 1254226095 | 15 |
News Archive
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
Research success through collaborative efforts of chemists and engineers from Berlin/Potsdam and Magdeburg. All of the best currently available pharmaceuticals against malaria can now be produced in pure form using a single process, even from the waste of the plant-extraction.
The introduction of a new, fully characterized viral vector for use as reference material to help standardize gene therapy protocols in research applications and human clinical trials is described in an article in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article, which is published online ahead of print, is available free online at www.liebertpub.com/hum
St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.
Scientists have provided the first evidence that an enzyme called Eya1 protein phosphatase is a critical regulator of lung function and that this may have broad implications for sufferers of a variety of pulmonary diseases.
› Verified 7 days ago
| Entity Name | Performance Therapies, Pc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1831122837 PECOS PAC ID: 1254226095 Enrollment ID: O20140829001681 |
News Archive
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
Research success through collaborative efforts of chemists and engineers from Berlin/Potsdam and Magdeburg. All of the best currently available pharmaceuticals against malaria can now be produced in pure form using a single process, even from the waste of the plant-extraction.
The introduction of a new, fully characterized viral vector for use as reference material to help standardize gene therapy protocols in research applications and human clinical trials is described in an article in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article, which is published online ahead of print, is available free online at www.liebertpub.com/hum
St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.
Scientists have provided the first evidence that an enzyme called Eya1 protein phosphatase is a critical regulator of lung function and that this may have broad implications for sufferers of a variety of pulmonary diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judy Jicinsky, PT 1585 Eagle View Ct Nw, Swisher, IA 52338-9437 Ph: (319) 981-2276 | Judy Jicinsky, PT 625 32nd Ave Sw, Cedar Rapids, IA 52404-3947 Ph: (319) 363-2901 |
News Archive
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
Research success through collaborative efforts of chemists and engineers from Berlin/Potsdam and Magdeburg. All of the best currently available pharmaceuticals against malaria can now be produced in pure form using a single process, even from the waste of the plant-extraction.
The introduction of a new, fully characterized viral vector for use as reference material to help standardize gene therapy protocols in research applications and human clinical trials is described in an article in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article, which is published online ahead of print, is available free online at www.liebertpub.com/hum
St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.
Scientists have provided the first evidence that an enzyme called Eya1 protein phosphatase is a critical regulator of lung function and that this may have broad implications for sufferers of a variety of pulmonary diseases.
› Verified 7 days ago
Dr. Stanley John Mathew, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Suite 3026, Cedar Rapids, IA 52402 Phone: 319-369-7331 | |
Mr. Devin Robert Hilar Smith, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7331 Fax: 319-369-8251 | |
Kyle Bernard, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 645 32nd Ave Sw, Cedar Rapids, IA 52404 Phone: 319-363-2901 Fax: 319-363-2903 | |
Nicholas R Appleby, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7211 | |
Dr. Roman Magid, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 855 A Ave Ne Ste 105, Cedar Rapids, IA 52402 Phone: 319-368-5992 | |
Aaron Sloterdyk, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 645 32nd Ave Sw Ste A, Cedar Rapids, IA 52404 Phone: 319-363-2901 Fax: 319-363-2903 | |
Craig A Dove, D.O. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7331 Fax: 319-369-8251 |